SEROMYCIN is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Parsolex Gmp Center, Inc.. The primary component is Cycloserine.
| Product ID | 13845-1200_b67c1b1d-7687-427a-a07a-e8100c046f73 | 
| NDC | 13845-1200 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | SEROMYCIN | 
| Generic Name | Cycloserine | 
| Dosage Form | Capsule | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2009-03-01 | 
| Marketing Category | ANDA / ANDA | 
| Application Number | ANDA060593 | 
| Labeler Name | Parsolex Gmp Center, Inc. | 
| Substance Name | CYCLOSERINE | 
| Active Ingredient Strength | 250 mg/250mg | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2009-03-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | ANDA | 
| Application Number | ANDA060593 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2009-03-01 | 
| Marketing Category | ANDA | 
| Application Number | ANDA060593 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2009-03-01 | 
| Ingredient | Strength | 
|---|---|
| CYCLOSERINE | 250 mg/250mg | 
| SPL SET ID: | e1e08327-4b90-463e-bb2a-22438cabcef2 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 13845-1200 | SEROMYCIN | CYCLOSERINE | 
| 13845-1203 | Seromycin | CycloSERINE | 
| 13845-1201 | CYCLOSERINE | CYCLOSERINE | 
| 13845-1202 | Cycloserine | Cycloserine | 
| 33342-462 | Cycloserine | Cycloserine | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  SEROMYCIN  88630156  not registered Live/Pending | Parsolex GMP Center, Inc. 2019-09-25 | 
|  SEROMYCIN  72016353  0649601 Live/Registered | ELI LILLY AND COMPANY 1956-09-25 |